Regencell Bioscience Holdings Limited
RGC
Kedudukan dalam Saham
#3440
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Harga Saham
$9.47
Modal Pasaran
$4.70B
Perubahan (1 hari)
-5.77%
Perubahan (1 tahun)
-44.16%
Negara
HK
Perdagangan Regencell Bioscience Holdings Limited (RGC)
Kategori
Healthcare
EPS untuk Regencell Bioscience Holdings Limited (RGC)
EPS setakat June 2026 TTM: $-0.02
Menurut laporan kewangan terkini dan harga saham Regencell Bioscience Holdings Limited, EPS semasa syarikat (TTM) adalah $-0.02. Pada akhir tahun 2024, syarikat mempunyai EPS sebanyak $-0.01 sama dengan EPS tahun 2023 iaitu $-0.01.
Sejarah EPS untuk Regencell Bioscience Holdings Limited dari 2019 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $-0.02 | 136.00% |
| 2025 | $-0.01 | -17.24% |
| 2024 | $-0.01 | -26.89% |
| 2023 | $-0.01 | -20.67% |
| 2022 | $-0.02 | 435.71% |
| 2021 | 0.00 | 64.71% |
| 2020 | 0.00 | 112.50% |
| 2019 | 0.00 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -2,457.20% |
IN
|
